Targeting nitric oxide for cancer therapy

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 1, 2007, Pages 3-13

  Hirst, David ^a   Robson, Tracy ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROGEN OXIDE; PEROXYNITRITE;

ANGIOGENESIS; APOPTOSIS; BLOOD FLOW; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CHEMOSENSITIZATION; DRUG MECHANISM; HUMAN; IMMUNOSURVEILLANCE; METASTASIS; NECROSIS; NONHUMAN; PROTEIN EXPRESSION; RADIOSENSITIZATION; REVIEW; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HUMANS; NEOPLASMS; NITRIC OXIDE;

EID: 33846360376     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.1.0002     Document Type: Review

References (155)

1. Albina, J. E., Reichner, J. S. (1998) Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev. 17: 39-53
2. Andrew, P. J., Harant, H., Lindley, I. J. (1995) Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214: 949-956
3. Azizzadeh, B., Yip, H. T., Blackwell, K. E., Horvath, S., Calcaterra, T. C., Buga, G. M., Ignarro, L. J., Wang, M. B. (2001) Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 111: 1896-1900
4. Babal, P., Pechanova, O., Bernatova, I., Stvrtina, S. (1997) Chronic inhibition of NO synthesis produces myocardial fibrosis and arterialmedia hyperplasia. Histol. Histopathol. 12: 623-629
5. Bal-Price, A., Brown, G. C. (2000) Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochem. 75: 1455-1464
6. Brennan, P. A. (2000) The actions and interactions of nitric oxide in solid tumours. Eur. J. Surg. Oncol. 26: 434-437
7. Bulut, A. S., Erden, E., Sak, S. D., Doruk, H., Kursun, N., Dincol, D. (2005) Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Virchows Arch. 447: 24-30
8. Chao, J. I., Kuo, P. C., Hsu, T. S. (2004) Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J. Biol. Chem. 279: 20267-20276
9. Charalambous, C., Pen, L. B., Su, Y. S., Milan, J., Chen, T. C., Hofman, F. M. (2005) Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res. 65: 10347-10354
10. Chen, H. H., Su, W. C., Chou, C. Y., Guo, H. R., Ho, S. Y., Que, J., Lee, W. Y. (2005) Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 63: 1093-1100
11. Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., Esumi, H. (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15: 437-442
12. Chinje, E. C., Stratford, I. J. (1997) Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem. 32: 61-72
13. Chung, P., Cook, T., Liu, K., Vodovotz, Y., Zamora, R., Finkelstein, S., Billiar, T., Blumberg, D. (2003) Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide 8: 119-126
14. Cook, T., Wang, Z., Alber, S., Liu, K., Watkins, S. C., Vodovotz, Y., Billiar, T. R., Blumberg, D. (2004) Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res. 64: 8015-8021
15. Dedon, P. C., Tannenbaum, S. R. (2004) Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423: 12-22
16. De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., Musiani. P., Zanovello, P., Bronte, V. (2005) Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl. Acad. Sci. USA 102: 4185-4190
17. de Wilt, J. H., Manusama, E. R., van Etten, B., van Tiel, S. T., Jorna, A. S., Seynhaeve, A. L., ten Hagen, T. L., Eggermont, A. M. (2000) Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions. Br. J. Cancer 83: 1176-1182
18. Dewey, D. L. (1960) Effect of oxygen and nitric oxide on the radiosensitivity of human cells in tissue culture. Nature 186: 780-782
19. Duenas-Gonzalez, A., Isales, C. M., del Mar Abad-Hernandez, M., Gonzalez-Sarmiento, R., Sangueza, O., Rodriguez-Commes, J. (1997) Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol. 10: 645-649
20. Ekmekcioglu, S., Tang, C. H., Grimm, E. A. (2005) NO news is not necessarily good news in cancer. Curr. Cancer Drug Targets 5: 103-115
21. Evig, C. B., Kelley, E. E., Weydert, C. J., Chu, Y., Buettner, G. R., Burns, C. P. (2004) Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts. Nitric Oxide 10: 119-129
22. Fabbri, F., Brigliadori, G., Ulivi, P., Tesei, A., Vannini, I., Rosetti, M., Bravaccini, S., Amadori, D., Bolla, M., Zoli, W. (2005) Proapoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells. Apoptosis 10: 1095-1103
23. Folkes, L. K., Wardman, P. (2004) Kinetics of the reaction between nitric oxide and glutathione: implications for thiol depletion in cells. Free Radic. Biol. Med. 37: 549-556
24. Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82: 4-6
25. Ford, E., Hughes, M. N., Wardman, P. (2002) Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. Free Radic. Biol. Med. 32: 1314-1323
26. Franchi, A., Santucci, M., Masini, E., Sardi, I., Paglierani, M., Gallo, O. (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95: 1902-1910
27. Franchi, A., Massi, D., Santucci, M., Masini, E., Degl'innocenti, D. R., Magnelli, L., Fanti, E., Naldini, A., Ardinghi, C., Carraro, F., Gallo, O. (2005) Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J. Pathol. 208: 439-445
28. Frank, S., Stallmeyer, B., Kampfer, H., Kolb, N., Pfeilschifter, J. (1999a) Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 113: 2002-2014
29. Frank, S., Stallmeyer, B., Kampfer, H., Schaffner, C., Pfeilschifter, J. (1999b) Differential regulation of vascular endothelial growth factor and its receptor-fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem. J. 338: 367-374
30. Fukumura, D., Yuan, F., Endo, M., Jain, R. K. (1997) Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150: 713-725
31. Gansauge, S., Nussler, A. K., Beger, H. G., Gansauge, F. (1998) Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 9:611-617
32. Gao, J., Liu, X., Rigas, B. (2005) Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. USA 102: 17207-17212
33. Gatti, G., Simsek, S., Zurrida, S., Kurne, A., Giannetti, I., Demirer, S., Smeets, A., Caldarella, P., Vento, A. R., Giraldo, A., Luini, A. (2004) Possible role of nitric oxide in the biology of breast carcinoma: review of the available literature. Breast 13: 1-6
34. Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., Scott, O. C. (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26: 638-648
35. Gray, L. H., Green, F. O., Hawes, C. A. (1958) Effect of nitric oxide on the radiosensitivity of tumour cells. Nature 182: 952-953
36. Graziewicz, M., Wink, D. A., Laval, F. (1996) Nitric oxide inhibits DNA ligase activity. Potential mechanisms for NO mediated DNA damage. Carcinogenesis 17: 2501-2505
37. Griffin, R. J., Makepeace, C. M., Hur, W. J., Song, C. W. (1996) Radiosensitization of hypoxic tumor cells in vitro by nitric oxide. Int. J. Radiat. Oncol. Biol. Phys. 36: 377-383
38. Guo, J.-P., Panday, M. M., Consigny, P. M., Lefer, A. M. (1995) Mechanisms of vascular preservation by a novel NO donor following carotid artery intimal injury. Am. J. Physiol. 269: H1122-H1131
39. Gursoy-Ozdemir, Y., Bolay, H., Saribas, O., Dalkara, T. (2000) Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 31: 1974-1980
40. Halliwell, B., Zhao, K., Whiteman, M. (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31: 651-669
41. Hara, A., Okayasu, I. (2004) Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol (Berl) 108: 43-48
42. Harada, K., Supriatno, Kawaguchi, S., Tomitaro, O., Yoshida, H., Sato, M. (2004) Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo 18: 449-455
43. Harmey, J. H., Bucana, C. D., Lu, W., Byrne, A. M., McDonnell, S., Lynch, C., Bouchier-Hayes, D., Dong, Z. (2002) Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int. J. Cancer 101: 415-422
44. Harris, A. L. (2002) Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2: 38-47
45. Hegardt, P., Widegren, B., Li, L., Sjogren, B., Kjellman, C., Sur, I., Sjogren, H. O. (2001) Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma. Cancer Immunol. Immunother. 50: 491-501
46. Hellmuth, M., Paulukat, J., Ninic, R., Pfeilschifter, J., Muhl, H. (2004) Nitric oxide differentially regulates pro- and anti-angiogenic markers in DLD-1 colon carcinoma cells. FEBS Lett. 563: 98-102
47. Hino, M., Kohchi, C., Nishizawa, T., Yoshida, A., Nakata, K., Inagawa, H., Hori, H., Makino, K., Terada, H., Soraa, G. (2005) Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide. Anticancer Res. 25: 3747-3754
48. Howard-Flanders, P. (1957) Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180: 1191-1192
49. Hu, D. E., Dyke, S. O., Moore, A. M., Thomsen, L. L., Brindle, K. M. (2004) Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res. 64: 152-161
50. Huguenin, S., Vacherot, F., Kheuang, L., Fleury-Feith, J., Jaurand, M. C., Bolla, M., Riffaud, J. P., Chopin, D. K. (2004) Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines. Mol. Cancer Ther. 3: 291-298
51. Huguenin, S., Vacherot, F., Fleury-Feith, J., Riffaud, J. P., Chopin, D. K., Bolla, M., Jaurand, M. C. (2005) Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines. Cancer Lett. 218: 163-170
52. Hussain, S. P., Trivers, G. E., Hofseth, L. J., He, P., Shaikh, I., Mechanic, L. E., Doja, S., Jiang, W., Subleski, J., Shorts, L., Haines, D., Laubach, V. E., Wiltrout, R. H., Djurickovic, D., Harris, C. C. (2004) Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res. 64: 6849-6853
53. Isenberg, J. S., Ridnour, L. A., Perruccio, E. M., Espey, M. G., Wink, D. A., Roberts, D. D. (2005) Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP dependent manner. Proc. Natl. Acad. Sci. USA 102: 13141-13146.
54. Ishii, Y., Ogura, T., Tatemichi, M., Fujisawa, H., Otsuka, F., Esumi, H. (2003) Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int. J. Cancer 103: 161-168
55. Jadeski, L. C., Lala, P. K. (1999) Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am. J. Pathol. 155: 1381-1390
56. Jadeski, L. C., Hum, K. O., Chakraborty, C., Lala, P. K. (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86: 30-39
57. Jadeski, L. C., Chakraborty, C., Lala, P. K. (2003) Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer 106:496-504
58. Janssens, M. Y., Van den Berge, D. L., Verovski, V. N., Monsaert, C., Storme, G. A. (1998) Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res. 58: 5646-5648
59. Janssens, M. Y., Verovski, V. N., Van den Berge, D. L., Monsaert, C., Storme, G. A. (1999) Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br. J. Cancer 79: 1085-1089
60. Jia, L., Schweizer, J., Wang, Y., Cerna, C., Wong, H., Revilla, M. (2003) Effect of nitric oxide on cytotoxicity of Taxol: enhanced Taxol transcellular permeability. Biochem. Pharmacol. 66: 2193-2199
61. Jones, M. K., Tsugawa, K., Tarnawski, A. S., Baatar, D. (2004) Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem. Biophys. Res. Commun. 318: 520-528
62. Jordan, B. F., Misson, P., Demeure, R., Baudelet, C., Beghein, N., Gallez, B. (2000) Changes in tumor oxygenation/perfusion induced by the NO donor, isosorbidedinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys. 48: 565-570
63. Jourd'heuil, D., Jourd'heuil, F. L., Kutchukian, P. S., Musah, R. A., Wink, D. A., Grisham, M. B. (2001) Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J. Biol. Chem. 276: 28799-28805
64. Juang, S. H., Xie, K., Xu, L., Wang, Y., Yoneda, J., Fidler, I. J. (1997) Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma. Cancer Biother. Radiopharm. 12: 167-175
65. Juang, S. H., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J., Fidler, I. J. (1998) Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther. 9: 845-854
66. Jurasz, P., Sawicki, G., Duszyk, M., Sawicka, J., Miranda, C., Mayers, I., Radomski, M. W. (2001) Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res. 61:376-382
67. Kanagy, N. L. (1997) Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am. J. Physiol. 273: H2756-H2764
68. Kashfi, K., Rigas, B. (2005) Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem. Soc. Trans. 33: 701-704
69. Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., Fukumura, D. (2005) NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 115: 1816-1827
70. Kasper, H. U., Wolf, H., Drebber, U., Wolf, H. K., Kern, M. A. (2004) Expression of inducible nitric oxide synthase, and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density. World J. Gastroenterol. 10: 1918-1922
71. Kennovin, G. D., Hirst, D. G., Stratford, M. R. L., Flitney, F. W. (1994) Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumour growth. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E. A. (eds) The Biology of nitric oxide. Portland Press, London, pp 259-263
72. Konovalova, N. P., Goncharova, S. A., Volkova, L. M., Rajewskaya, T. A., Eremenko, L. T., Korolev, A. M. (2003) Nitric oxide donor increases the efficiency of cytostatic therapy and retards the development of drug resistance. Nitric Oxide 8: 59-64
73. Korbelik, M., Parkins, C. S., Shibuya, H., Cecic, I., Stratford, M. R., Chaplin, D. J. (2000) Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br. J. Cancer 82: 1835-1843
74. 2+complexes: unique molecular switches for inducible nitric oxide synthase-derived NO. FASEB J. 15: 2503-2507
75. Kroncke, K. D., Klotz, L. O., Suschek, C. V., Sies, H. (2002) Comparing nitrosative versus oxidative stress toward zinc finger-dependent transcription. Unique role for NO. J. Biol. Chem. 277: 13294-13301
76. Kuroki, M. (2004) Gene therapy in cancer via use of a retrovector having a tumor specificity and expressing inducible nitric oxide synthase. Methods Mol. Biol. 279: 201-211
77. Kuroki, M., Arakawa, F., Khare, P. D., Kuroki, M., Liao, S., Matsumoto, H., Abe, H., Imakiire, T. (2000) Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA. Anticancer Res. 20: 4067-4071
78. Kwak, J. Y., Han, M. K., Choi, K. S., Park, I. H., Park, S. Y., Sohn, M. H., Kim, U. H., McGregor, J. R., Samlowski, W. E., Yim, C. Y. (2000) Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell Immunol. 203: 84-94
79. Lala, P. K., Chakraborty, C. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2: 149-156
80. Laskin, J. D., Heck, D. E., Gardner, C. R., Laskin, D. L. (2001) Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxid. Redox Signal. 3: 261-271
81. Lau, Y.-T., Ma, W.-C. (1996) Nitric oxide inhibits migration of cultured endothelial cells. Biochem. Biophys. Res. Commun. 221: 670-674
82. Laval, F., Wink D. A. (1997) Inhibition by nitric oxide of the repair protein O6-methylguanin-DNA-methyltransferase. Carcinogenesis 15: 443-447
83. Le, X., Wei, D., Huang, S., Lancaster, J. R., Xie, K. (2005) Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA 102: 8758-8763
84. Lechner, M., Lirk, P., Rieder, J. (2005) Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15: 277-289
85. Leiro, J., Iglesias, R., Parama, A., Sanmartin, M. L., Ubeira, F. M. (2001) Respiratory burst responses of rat macrophages to microsporidian spores. Exp. Parasitol. 98: 1-9
86. Li, H., Hu, J., Xin, W., Zhao, B. (2000) Production and interaction of oxygen and nitric oxide free radicals in PMA stimulated macrophages during the respiratory burst. Redox Rep. 5: 353-358
87. Li, W., Xu, R. J., Jiang, L. H., Shi, J., Long, X., Fan, B. (2005) Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma. Med. Oncol. 22: 63-70
88. Liu, J., Li, C., Qu, W., Leslie, E., Bonifant, C. L., Buzard, G. S., Saavedra, J. E., Keefer, L. K., Waalkes, M. P. (2004) Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol. Cancer Ther. 3: 709-714
89. Loibl, S., Buck, A., Strank, C., von Minckwitz, G., Roller, M., Sinn, H. P., Schini-Kerth, V., Solbach, C., Strebhardt, K., Kaufmann, M. (2005) The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur. J. Cancer 41: 265-271
90. Marrogi, A. J., Travis, W. D., Welsh, J. A., Khan, M. A., Rahim, H., Tazelaar, H., Pairolero, P., Trastek, V., Jett, J., Caporaso, N. E., Liotta, L. A., Harris, C. C. (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res. 6: 4739-4744
91. Matsumoto, H., Hayashi, S., Hatashita, M., Ohnishi, K., Shioura, H., Ohtsubo, T., Kitai, R., Ohnishi, T., Kano, E. (2001) Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat. Res. 155: 387-396
92. Matsunaga, T., Weihrauch, D. W., Moniz, M. C., Tessmer, J., Warltier, D. C., Chilian, W. M. (2002) Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105: 2185-2191
93. Meyer, R. E., Shan, S., DeAngelo, J., Dodge, R. K., Bonaventura, J., Ong, E. T., Dewhirst, M. W. (1995) Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br. J. Cancer 71: 1169-1174
94. Mitchell, J. B., Wink, D. A., DeGraff, W., Gamson, J., Keefer, L. K., Krishna, M. C. (1993) Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res. 53: 5845-5848
95. Mitchell, J. B., Cook, J. A., Krishna, M. C., DeGraff, W., Gamson, J., Fisher, J., Christodoulou, D., Wink, D. A. (1996) Radiation sensitisation by nitric oxide releasing agents. Br. J. Cancer 27(Suppl.): S181-184
96. Mitchell, J. B., DeGraff, W., Kimi, S., Cook, J. A., Gamson, J., Christodoulou, D., Feelisch, M., Wink, D. A. (1998) Redox generation of nitric oxide to radiosensitize hypoxic cells. Int. J. Radiat. Oncol. Biol. Phys. 42: 795-798
97. Moncada, S. (1999) Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92: 164-169
98. Moncada, S., Higgs, E. A. (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361-374
99. Mortensen, K., Skouv, J., Hougaard, D. M., Larsson, L. I. (1999) Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274: 37679-37684
100. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., Huang, P. L., Isner, J. M. (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 2567-2578
101. Nabah, Y. N., Mateo, T., Cerda-Nicolas, M., Alvarez, A., Martinez, M., Issekutz, A. C., Sanz, M. J. (2005) L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II. Microcirculation 12: 443-453
102. Orucevic, A., Lala, P. K. (1996) Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell Immunol. 169: 125-132
103. Oshima, T., Imada, T., Nagashima, Y., Cho, H., Shiozawa, M., Rino, Y., Takanashi, Y. (2001) Role of nitric oxide in human gastric cancer cells treated with 5 fluorouracil. Oncol. Rep. 8: 847-849
104. Osorio, J. C., Recchia, F. A. (2000) The role of nitric oxide in metabolism regulation: from basic sciences to the clinical setting. Intensive Care Med. 26: 1395-1398
105. Palmer, R. M., Ferrige, A. G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526
106. Pan, J. W., Zhan, R. Y., Tong, Y., Zhou, Y. Q., Zhang, M. (2005) Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma. J. Zhejiang Univ. Sci. B. 6: 693-698
107. Pechanova, O., Bernatova, I., Babal, P., Martinez, M. C., Kysela, S., Stvrtina, S., Andriantsitohaina, R. (2004) Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens. 22: 1551-1559
108. Pervin, S., Singh, R., Gau, C. L., Edamatsu, H., Tamanoi, F., Chaudhuri, G. (2001) Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer. Cancer Res. 61: 4701-4706
109. Phillips, P. G., Birnby, L. M. (2004) Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1055-L1065
110. Pipili-Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., Maragoudakis, M. E. (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111: 894-902
111. Powell, J. A., Mohamed, S. N., Kerr, J. S., Mousa, S. A. (2000) Antiangiogenesis efficacy of nitric oxide donors. J Cell Biochem. 80: 104-114
112. Puhakka, A., Kinnula, V., Napankangas, U., Saily, M., Koistinen, P., Paakko, P., Soini, Y. (2003) High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS 111: 1137-1146
113. Raspollini, M. R., Amunni, G., Villanucci, A., Boddi, V., Baroni, G., Taddei, A., Taddei, G. L. (2004) Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol. Oncol. 92: 806-812
114. RayChaudhury, A., Frischer, H., Malik, A. B. (1996) Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide. J. Cell Biochem. 63: 125-134
115. Ridnour, L. A., Isenberg, J. S., Espey, M. G., Thomas, D. D., Roberts, D. D., Wink, D. A. (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl. Acad. Sci. USA 102: 13147-13152
116. Royle, J. S., Ross, J. A., Ansell, I., Bollina, P., Tulloch, D. N., Habib, F.K. (2004) Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J. Urol. 172: 338-344
117. Rubio, L., Vera-Sempere, F. J., Lopez-Guerrero, J. A., Padilla, J., Moreno-Baylach, M. J. (2005) A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression. Anticancer Res. 25: 497-504
118. Schimmel, M., Bauer, G. (2001) Selective apoptosis induction in transformed fibroblasts by B cell lines: involvement of reactive oxygen and nitrogen species. Int. J. Oncol. 19: 299-304
119. Shao, C., Stewart, V., Folkard, M., Michael, B. D., Prise, K. M. (2003) Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Res 63: 8437-8442
120. Shizukuda, Y., Tang, S., Yokota, R., Ware, J. A. (1999) Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinaseCdelta activity. Circ. Res. 85: 247-256
121. Sidorkina, O., Espey, M. G., Miranda, K. M., Wink, D. A., Laval, J. (2003) Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic. Biol. Med. 35: 1431-1438
122. Sokolov, M. V., Smilenov, L. B., Hall, E. J., Panyutin, I. G., Bonner, W. M., Sedelnikova, O. A. (2005) Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 24: 7257-7265
123. Soler, M. N., Bobe, P., Benihoud, K., Lemaire, G., Roos, B. A., Lausson, S. (2000) Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J. Gene Med. 2: 344-352
124. Somers, M. J., Harrison, D. G. (1999) Reactive oxygen species and the control of vasomotor tone. Curr. Hypertens. Rep. 1: 102-108
125. Son, K. K., Hall, K. J. (2000) Nitric oxide-mediated tumor cell killing of cisplatin-based interferon-gamma gene therapy in murine ovarian carcinoma. Cancer Gene Ther. 7: 1324-1328
126. Sonveaux, P., Brouet, A., Havaux, X., Gregoire, V., Dessy, C., Balligand, J. L., Feron, O. (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 63: 1012-1019
127. Srivastava, R. C., Farookh, A., Ahmad, N., Misra, M., Hasan, S. K., Husain, M. M. (1996) Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 9: 139-142
128. Swaroop, G. R., Malcolm, G. P., Kelly, P. A., Ritchie, I., Whittle, I. R. (1998) Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. Neuroreport 9: 2577-2581
129. Szabo, C., Ohshima, H. (1997) DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1: 373-385
130. Thomsen, L. L., Scott, J. M., Topley, P., Knowles, R. G., Keerie, A. J., Frend, A. J. (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57: 3300-3304
131. Tozer, G. M., Everett, S. A. (1997) Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects. Clin. Oncol. (R Coll Radiol) 9: 282-293
132. Tozer, G. M., Prise, V. E., Chaplin, D. J. (1997) Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res. 57: 948-955
133. Tozer, G. M., Prise, V. E., Motterlini, R., Poole, B. A., Wilson, J., Chaplin, D. J. (1998) The comparative effects of the NOS inhibitor, Nomega-nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow. Int. J. Radiat. Oncol. Biol. Phys. 42: 849-853
134. Tschugguel, W., Pustelnik, T., Lass, H., Mildner, M., Weninger, W., Schneeberger, C., Jansen, B., Tschachler, E., Waldhor, T., Huber, J. C., Pehamberger, H. (1999) Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br. J. Cancer 79: 1609-1612
135. Tse, G. M., Wong, F. C., Tsang, A. K., Lee, C. S., Lui, P. C., Lo, A. W., Law, B. K., Scolyer, R. A., Karim, R. Z., Putti, T. C. (2005) Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J. Clin. Pathol. 58: 600-604
136. Wakabayashi, Y., Shono, T., Hori, S., Matsushima, K., Ono, M., Kuwano, M. (1995) Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: VEGF/bFGF and IL-8. Jpn. J. Cancer Res. 86: 1189-1197
137. Wang, G. Y., Ji, B., Wang, X., Gu, J. H. (2005) Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J. Gastroenterol. 11: 3830-3833
138. Wang, Z., Cook, T., Alber, S., Liu, K., Kovesdi, I., Watkins, S. K., Vodovotz, Y., Billiar, T. R., Blumberg, D. (2004) Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res. 64: 1386-1395
139. Watanabe, K., Hess, A., Michel, O., Yagi, T. (2000) Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs. Anticancer Drugs 11: 731-735
140. Wei, D., Richardson, E. L., Zhu, K., Wang, L., Le, X., He, Y., Huang, S., Xie, K. (2003) Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res. 63: 3855-3859
141. Williams, E. L., Djamgoz, M. B. (2005) Nitric oxide and metastatic cell behaviour. Bioessays 27: 1228-1238
142. Wink, D. A., Laval, J. (1994) The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 15: 2125-2129
143. Wink, D. A., Hanbauer, I., Krishna, M. C., DeGraff, W., Gamson, J., Mitchell, J. B. (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA. 90: 9813-9817
144. Wink, D. A., Cook, J. A., Christodoulou, D., Krishna, M. C., Pacelli, R., Kim, S., DeGraff, W., Gamson, J., Vodovotz, Y., Russo, A., Mitchell, J. B. (1997) Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1: 88-94
145. Wink, D. A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M. W., Mitchell, J. B. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19: 711-721
146. Worthington, J., Robson, T., O'Keeffe, M., Hirst, D. G. (2002) Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther. 9: 263-269
147. Worthington, J., McCarthy, H. O., Barrett, E., Adams, C., Robson, T., Hirst, D. G. (2004) Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J. Gene Med. 6: 673-680
148. Worthington, J., Robson, T., Scott, S., Hirst, D. (2005) Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer. Gene Ther. 12: 1417-1423
149. Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., Maeda, H. (2001) Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn. J. Cancer Res. 92: 439-451
150. Xiong, Y., Yuan, L. W., Deng, H. W., Li, Y. J., Chen, B. M. (2001) Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28: 842-847
151. Yamaguchi, K., Saito, H., Oro, S., Tatebe, S., Ikeguchi, M., Tsujitani, S. (2005) Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68: 471-478
152. Yang, D. I., Yin, J. H., Ju, T. C., Chen, L. S., Hsu, C. Y. (2004) Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S- nitrosoglutathione. Free Radic. Biol. Med. 36: 1317-1328
153. Yin, J. H., Yang, D. I., Chou, H., Thompson, E. M., Xu, J., Hsu, C. Y. (2001) Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J. Pharmacol. Exp. Ther. 297: 308-315
154. Zhang, X. M., Xu, Q. (2001) Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes. Melanoma Res. 11: 559-567
155. Ziche, M., Morbidelli, L. (2000) Nitric oxide and angiogenesis. J. Neurooncol. 50: 139-148